Lu Ye, Yang Yicheng, Fu Yinghui, Xiong Changming, Li Fajiu, Zhou Xiaoming
Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Respiratory Department, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Thorac Dis. 2025 Feb 28;17(2):724-743. doi: 10.21037/jtd-24-954. Epub 2025 Feb 27.
Chronic thromboembolic pulmonary hypertension (CTEPH), a progressive disease, can lead to decompensation of the right half of the heart and death. Studies on CTEPH have increased in number over the last two decades. This study aimed to perform a bibliometric analysis of the global scientific output on CTEPH in the last 24 years to identify research trends and hot topics.
We searched the Web of Science Core Collection (WoSCC) Science Citation Index Expanded (Science Citation Index Expanded and Social Sciences Citation Index) for literature on CTEPH published from January 1, 2000 to January 31, 2024, and recorded their information. The Bibliometrix software package was used for bibliometric indicator analysis, and VOSviewer and CiteSpace were used to visualize trends and hotspots of CTEPH research.
Overall, 2,264 publications were included in the bibliometric analysis. The number of annual publications increased drastically from 14 in 2000 to 199 in 2023. The number of publications on CTEPH has increased over the last two decades, with 24.4% (n=553) of the publications published in top academic journals. The United States ranked first in publications and had the best CTEPH-investigating institutions; it also had the highest level of international cooperation. Distinctively, 7 of the top 10 institutions and 7 of the top 10 researchers in the field were from Europe with the most influential scientists. A relatively high percentage of the publications were published in top-rank academic journals, especially in respirology and cardiology journals. Pulmonary endarterectomy (PEA) was the main therapy during the first decade, while balloon pulmonary angioplasty (BPA) and pulmonary arterial hypertension (PAH)-targeted medicine have recently gained interest. Dual-energy computed tomography (DECT), right ventricular function, and the role of pulmonary endothelium in microvasculopathy have become the focus of CTEPH research.
The number of publications on CTEPH has increased over the last two decades, and CTEPH has become a significant topic in both respirology and cardiology. Our results indicate that future research in this field will continue to focus on elucidating the pathophysiological mechanisms underlying this disorder, improving diagnostic accuracy, and developing novel imaging techniques. The integration of existing therapeutic modalities and the elucidation of right ventricular dysfunction are key areas of research.
慢性血栓栓塞性肺动脉高压(CTEPH)是一种进行性疾病,可导致右心功能不全和死亡。在过去二十年中,关于CTEPH的研究数量有所增加。本研究旨在对过去24年全球CTEPH科学产出进行文献计量分析,以确定研究趋势和热点话题。
我们在科学网核心合集(WoSCC)科学引文索引扩展版(科学引文索引扩展版和社会科学引文索引)中搜索了2000年1月1日至2024年1月31日发表的关于CTEPH的文献,并记录其信息。使用文献计量学软件包进行文献计量指标分析,使用VOSviewer和CiteSpace对CTEPH研究的趋势和热点进行可视化。
总体而言,文献计量分析纳入了2264篇出版物。年出版物数量从2000年的14篇急剧增加到2023年的199篇。在过去二十年中,关于CTEPH的出版物数量有所增加,其中24.4%(n = 553)发表在顶级学术期刊上。美国在出版物数量上排名第一,拥有最好的CTEPH研究机构;其国际合作水平也最高。值得注意的是,该领域排名前十的机构中有7个和排名前十的研究人员中有7个来自欧洲,且有最具影响力的科学家。相当高比例的出版物发表在顶级学术期刊上,尤其是呼吸病学和心脏病学期刊上。在第一个十年中,肺动脉内膜剥脱术(PEA)是主要治疗方法,而近年来球囊肺动脉成形术(BPA)和肺动脉高压(PAH)靶向药物受到关注。双能计算机断层扫描(DECT)、右心室功能以及肺内皮在微血管病变中的作用已成为CTEPH研究的重点。
在过去二十年中,关于CTEPH的出版物数量有所增加,CTEPH已成为呼吸病学和心脏病学中的一个重要话题。我们的结果表明,该领域未来的研究将继续专注于阐明这种疾病的病理生理机制、提高诊断准确性以及开发新的成像技术。整合现有治疗方式和阐明右心室功能障碍是关键研究领域。